Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Kluth, LA; Rink, M; Ahyai, SA; Fisch, M; Shariat, SF; Dahm, P.
[Randomized controlled trials terminated prematurely: beneficial therapy effects].
Urologe A. 2013; 52(8):1080-3
Doi: 10.1007/s00120-013-3144-2
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Ahyai Sascha
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Randomized controlled trials (RCTs) stopped prematurely for beneficial therapy effects are becoming increasingly more prevalent in the urological literature and often receive great attention in the public and medical media. Urologists who practice evidence-based medicine should be aware of the potential bias and the different reasons why and how early termination of RCTs can and will affect the results. This review provides insights into the challenges clinical urologists face by interpreting the results of prematurely terminated RCTs.
- Find related publications in this database (using NLM MeSH Indexing)
-
Bias - administration & dosage
-
Evidence-Based Medicine - administration & dosage
-
Humans - administration & dosage
-
Outcome Assessment, Health Care - methods, statistics & numerical data
-
Physicians - statistics & numerical data
-
Randomized Controlled Trials as Topic - methods, statistics & numerical data
- Find related publications in this database (Keywords)
-
Evidence-based medicine
-
Bias, epidemiological
-
Study termination, premature
-
Therapy effect